Safety and Tolerability of Low Dose Primaquine

PHASE4CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2016

Conditions
Malaria, FalciparumG6PD Deficiency
Interventions
DRUG

Dihydroartemisinin piperaquine (DHA PP)

DRUG

Primaquine

Trial Locations (1)

Unknown

Ratanakiri Provincial Hospital, Ratanakiri

All Listed Sponsors
collaborator

National Centre for Parasitology, Entomology and Malaria Control, Cambodia

OTHER

collaborator

Institute Pasteur, Cambodia

UNKNOWN

collaborator

World Health Organization

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Malaria Consortium

OTHER

NCT02434952 - Safety and Tolerability of Low Dose Primaquine | Biotech Hunter | Biotech Hunter